Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSTAMATINIB vs FRUQUINTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSTAMATINIB vs FRUQUINTINIB: Safety Overview

Metric FOSTAMATINIB FRUQUINTINIB
Total FAERS Reports 6,394 2,565
Deaths Reported 453 874
Death Rate 7.1% 34.1%
Hospitalizations 1,493 753
Average Patient Age 64.7 yrs 63.9 yrs
% Female Patients 60.8% 44.4%
FDA Approval Date Apr 17, 2018 Nov 8, 2023
Manufacturer Rigel Pharmaceuticals, Inc. Takeda Pharmaceuticals America, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription